Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP)

Chemistry and Biology

Volumn 7, Issue 11, 2000, Pages 855-871

  Krampert, Monika ^a,b   Bernhagen, Jürgen ^b   Schmucker, Jürgen ^b   Horn, Anita ^a   Schmauder, Anke ^a   Brunner, Herwig ^b   Voelter, Wolfgang ^a   Kapurniotu, Aphrodite ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Aggregation; Amyloidogenicity; Cytotoxicity; Islet amyloid polypeptide; Pro islet amyloid polypeptide

Indexed keywords

AMYLIN; AMYLOID; COLORING AGENT; CONGO RED; HYBRID PROTEIN; INSULINOMA AMYLOID POLYPEPTIDE PRECURSOR; PROTEIN PRECURSOR;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CIRCULAR DICHROISM; CYTOLOGY; DRUG EFFECT; ELECTRON MICROSCOPY; ESCHERICHIA COLI; GENE VECTOR; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; SOLUTION AND SOLUBILITY;

AMINO ACID SEQUENCE; AMYLOID; BASE SEQUENCE; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; COLORING AGENTS; CONGO RED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENETIC VECTORS; HUMANS; ISLETS OF LANGERHANS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SOLUTIONS; TUMOR CELLS, CULTURED;

EID: 0033758248     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00034-X     Document Type: Article

References (76)

1. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells
2. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type II diabetes
3. Possible links between amylin and diabetes
4. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
5. Structure and biology of amylin
6. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
7. Neurotoxicity of human amylin to rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid β-neurotoxicity
8. Effect of pH and insulin on fibrillogenesis of islet amyloid in vitro
9. β-Structure in human amylin and two designer β-peptides: CD and NMR spectroscopic comparisons suggest soluble β-oligomers and the absence of significant populations of β-strand dimers
10. Polymorphic fibrillar assembly of human amylin
11. Watching amyloid fibrils grow by time-lapse atomic force microscopy
12. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
13. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro
14. Interspecies variations affect the kinetics and thermodynamics of amyloid plaque formation: Peptide models of pancreatic amyloid
15. Islet amyloid polypeptide: A new β-cell secretory product related to islet amyloid deposits
16. Processing of pro-islet amyloid polypeptide (proIAPP) by the prohomone convertase PC 2
17. Seeding one-dimensional crystallization of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
18. A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide
19. Improved preparation of β-amyloid (1-43): Structural insights leading to optimized positioning of N-(2-hydroxy-4-methoxybenzyl) (Hmb) backbone amide protection
20. Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system
21. Induction of apoptosis by human amylin in RINm5F islet β-cells is associated with enhanced expression of p23 and p21WAF1/CIP1
22. Identification of a penta and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties
23. Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines. HIT-T15 and RINm5F cells
24. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles
25. Pore formation by the cytotoxic islet amyloid peptide amylin
26. A simple method of displaying the hydropathic character of a protein
27. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm
28. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs
29. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation
30. Selective amyloid staining as a function of amyloid composition and structure
31. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein
32. The anometer-scale structure of amyloid-β visualized by atomic force microscopy
33. Physical, morphological and functional differences between H 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ
34. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
35. Folding proteins
36. Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: A practical guide
37. Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroism
38. Deconvolution of the circular dichroism spectra of proteins: The circular dichroism spectra of the antiparallel β-sheet in proteins
39. Circular dichroism of peptides
40. Adsorption of proteins onto glass surfaces and its effect on the intensity of circular dichroism spectra
41. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
42. Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate
43. In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different sustrates: New insights into mechanism of β-sheet formation
44. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops
45. Production, purification, and cleavage of tandem repeats of recombinant peptides
46. Expression as trpE fusion
47. Amplification and purification of plasmid-encoded thioredox in from Escherichia coli K12
48. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein
49. Aggregation of truncated GST-HD exon 1 fusion proteins containing normal range and expanded glutamine repeats
50. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntingtons's disease pathology
51. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module
52. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae
53. In pursuit of the molecular structure of amyloid plaque: New technology provides unexpected and critical information
54. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
55. The most pathogenic transthyretin variant L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions
56. Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease
57. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease
58. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis
59. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded
60. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
61. The amyloidogenicity of gelsolin is controlled by proteolysis and pH
62. Pro-sequence-assisted protein folding
63. To fold or not to fold
64. For protein misassembly it's the 'l' decade
65. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
66. Conversion of α-helices into β-sheets features in the formation Of the scrapie prion proteins
67. Two conformational states of amyloid β-peptide: Implications for the pathogenesis of Alzheimer's disease
68. Aggregation of conjugated helical molecules
69. Diacetylenic lipid tubules: Experimental evidence for a chiral molecular architecture
70. The psi-type circular dichroism of large molecular aggregates. III. Calculations
71. Amyloid fibrillogenesis: Themes and variations
72. Protofilaments, filaments, ribbons, and fibrils from peptido-mimetic self-assembly: Implications for amyloid fibril formation and materials science
73. The toxicity in vitro of β-amyloid protein
74. β-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red
75. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
76. 1-42 are potent central nervous system neurotoxins